SPL Quarterly Cashflow and Activities Report 30/10/20 PRICE SENSITIVE download Created with Sketch. 184.83KB Share SPL Completion of Placement and SPP raises $48.9M in total 29/10/20 PRICE SENSITIVE download Created with Sketch. 50.98KB Share SPL Starpharma receives $5.7M R&D tax incentive refund 21/10/20 PRICE SENSITIVE download Created with Sketch. 51.17KB Share SPL Shareholder Update October 2020 20/10/20 download Created with Sketch. 467.84KB Share SPL Notice of Annual General Meeting/Proxy Form 19/10/20 download Created with Sketch. 3.1MB Share SPL Change in substantial holding 09/10/20 download Created with Sketch. 208.8KB Share SPL Change in substantial holding 08/10/20 download Created with Sketch. 187.66KB Share SPL Change in substantial holding 08/10/20 download Created with Sketch. 474.5KB Share SPL Change in substantial holding 08/10/20 download Created with Sketch. 1.65MB Share SPL Share Purchase Plan offer document 07/10/20 PRICE SENSITIVE download Created with Sketch. 398.73KB Share SPL Cleansing Notice 06/10/20 download Created with Sketch. 79.32KB Share SPL Appendix 2A 06/10/20 download Created with Sketch. 172.76KB Share SPL Change in Director's Interest Notice - R Thomas 05/10/20 download Created with Sketch. 74.28KB Share SPL Change in Director's Interest Notice - J Fairley 05/10/20 download Created with Sketch. 75.05KB Share SPL Proposed issue of Securities - SPL 30/09/20 download Created with Sketch. 34.05KB Share SPL Investor Presentation 30/09/20 download Created with Sketch. 3.13MB Share SPL Starpharma completes oversubscribed A$45M placement 30/09/20 PRICE SENSITIVE download Created with Sketch. 66.2KB Share SPL Trading Halt 28/09/20 PRICE SENSITIVE download Created with Sketch. 146.29KB Share SPL VivaGel BV secures TGA approval for prevention of BV 25/09/20 download Created with Sketch. 60.45KB Share SPL Appendix 2A 23/09/20 download Created with Sketch. 168.31KB Share SPL 2020 Annual General Meeting 23/09/20 download Created with Sketch. 49.17KB Share SPL Change in substantial holding 18/09/20 download Created with Sketch. 188.92KB Share SPL Starpharma to present at OTCQX Life Sciences Investor Forum 17/09/20 download Created with Sketch. 3.44MB Share SPL Change in substantial holding 17/09/20 download Created with Sketch. 216.29KB Share SPL SPL7013 COVID-19 nasal spray virucidal against SARS-CoV-2 14/09/20 PRICE SENSITIVE download Created with Sketch. 182.76KB Share SPL Change in substantial holding 03/09/20 download Created with Sketch. 159.51KB Share SPL Starpharma awarded $1M MRFF funding for COVID-19 spray 03/09/20 PRICE SENSITIVE download Created with Sketch. 93.54KB Share SPL SPL creates slow release soluble DEP remdesivir nanoparticle 01/09/20 PRICE SENSITIVE download Created with Sketch. 89.37KB Share SPL Change in substantial holding 01/09/20 download Created with Sketch. 219.32KB Share SPL Appendix 4G - Corporate Governance Statement 27/08/20 download Created with Sketch. 126.99KB Share SPL Starpharma annual report and full year financial results 27/08/20 PRICE SENSITIVE download Created with Sketch. 5.82MB Share SPL SPL7013 nasal spray for COVID19 development update 25/08/20 PRICE SENSITIVE download Created with Sketch. 266.09KB Share SPL Starpharma signs new DEP partnership with Chase Sun 17/08/20 PRICE SENSITIVE download Created with Sketch. 57.35KB Share SPL Quarterly Cashflow and Activities Report 30/07/20 PRICE SENSITIVE download Created with Sketch. 218.5KB Share SPL DEP docetaxel and gemcitabine combination trial commences 30/07/20 download Created with Sketch. 66.31KB Share SPL AZD0466 trial opens MD Anderson Cancer Center as a site 27/07/20 download Created with Sketch. 51.89KB Share SPL New Australian site opening for DEP trials 09/07/20 download Created with Sketch. 54.54KB Share SPL DEP irinotecan boosts immuno-oncology in colon cancer models 29/06/20 PRICE SENSITIVE download Created with Sketch. 111.67KB Share SPL DEP products showcased at AACR 2020 23/06/20 PRICE SENSITIVE download Created with Sketch. 67.38KB Share SPL Starpharma to present at OTCQX Virtual Investor Conference 18/06/20 download Created with Sketch. 43.69KB Share SPL DEP lutetium effective in human prostate cancer model 17/06/20 PRICE SENSITIVE download Created with Sketch. 108.55KB Share SPL VivaGel BV launched in central and eastern Europe 16/06/20 PRICE SENSITIVE download Created with Sketch. 56.59KB Share SPL Becoming a substantial holder 15/06/20 download Created with Sketch. 239.2KB Share SPL Becoming a substantial holder 26/05/20 download Created with Sketch. 918.39KB Share SPL Shareholder Update May 2020 14/05/20 download Created with Sketch. 605.69KB Share SPL DEP irinotecan phase 2 commences after positive phase 1 07/05/20 PRICE SENSITIVE download Created with Sketch. 108.92KB Share SPL Starpharma presents at Macquarie Australia Conference 05/05/20 download Created with Sketch. 48.97KB Share SPL SPL7013 shows significant activity against coronavirus 15/04/20 PRICE SENSITIVE download Created with Sketch. 68.84KB Share SPL Quarterly Cashflow and Activity Report 07/04/20 PRICE SENSITIVE download Created with Sketch. 499.69KB Share SPL Appendix 2A 20/03/20 download Created with Sketch. 274.14KB Share SPL Okamoto licenses VivaGel antiviral condom in Asian countries 04/03/20 PRICE SENSITIVE download Created with Sketch. 54.1KB Share SPL Starpharma appoints David McIntyre and Appendix 3X 02/03/20 download Created with Sketch. 256.18KB Share SPL Interim Report and Half-Year Financial Results 24/02/20 PRICE SENSITIVE download Created with Sketch. 554.35KB Share SPL VivaGel BV launched in Asia 13/02/20 PRICE SENSITIVE download Created with Sketch. 50.93KB Share SPL David McIntyre appointed as non-executive director 12/02/20 download Created with Sketch. 51.45KB Share SPL Starpharma receives US$3M milestone from AstraZeneca 11/02/20 PRICE SENSITIVE download Created with Sketch. 50.6KB Share SPL Shareholder Update January 2020 30/01/20 download Created with Sketch. 630.48KB Share SPL Quarterly Cashflow Report 29/01/20 PRICE SENSITIVE download Created with Sketch. 93.11KB Share SPL Appendix 3B 24/01/20 download Created with Sketch. 160.13KB Share SPL Commencement of phase 1 trial for AZD0466 utilising DEP 30/12/19 PRICE SENSITIVE download Created with Sketch. 57.86KB Share SPL Starpharma receives $4.9M R&D tax incentive refund 16/12/19 PRICE SENSITIVE download Created with Sketch. 49.98KB Share SPL DEP cabazitaxel progresses to phase 2 on positive results 10/12/19 PRICE SENSITIVE download Created with Sketch. 305.2KB Share SPL Change in Director's Interest Notice - J Fairley 04/12/19 download Created with Sketch. 165.72KB Share SPL Appendix 3B 04/12/19 download Created with Sketch. 163.41KB Share SPL AGM Results 21/11/19 download Created with Sketch. 193.06KB Share SPL AGM - Chairman address and CEO presentation 21/11/19 PRICE SENSITIVE download Created with Sketch. 3.35MB Share SPL VivaGel condom receives regulatory approval in Europe 20/11/19 PRICE SENSITIVE download Created with Sketch. 62.82KB Share SPL 2019 AGM details 19/11/19 download Created with Sketch. 42.62KB Share SPL UK launch of VivaGel BV 13/11/19 PRICE SENSITIVE download Created with Sketch. 73.67KB Share SPL Becoming a substantial holder - SPL 12/11/19 download Created with Sketch. 603.87KB Share SPL DEP outperforms Gemzar in human pancreatic cancer model 31/10/19 PRICE SENSITIVE download Created with Sketch. 104.09KB Share SPL Quarterly Cashflow Report 30/10/19 PRICE SENSITIVE download Created with Sketch. 178.02KB Share SPL Ceasing to be a substantial holder 23/10/19 download Created with Sketch. 41.5KB Share SPL Change in substantial holding 23/10/19 download Created with Sketch. 98.8KB Share SPL Notice of Annual General Meeting/Proxy Form 18/10/19 download Created with Sketch. 1.63MB Share SPL Appendix 3B 17/10/19 download Created with Sketch. 163.19KB Share SPL Starpharma to present at US Drug Delivery Conference 08/10/19 download Created with Sketch. 57.7KB Share SPL Change in Director's Interest Notice - J Fairley 01/10/19 download Created with Sketch. 74.82KB Share SPL Appendix 3B 01/10/19 download Created with Sketch. 159.26KB Share SPL FDA Authorises Clinical Trial with AstraZeneca DEP product 26/09/19 PRICE SENSITIVE download Created with Sketch. 64.77KB Share SPL AGM Date Notification 24/09/19 download Created with Sketch. 42.05KB Share SPL DEP irinotecan synergistic with Lynparza in refractory model 12/09/19 PRICE SENSITIVE download Created with Sketch. 116.83KB Share SPL Change in substantial holding 09/09/19 download Created with Sketch. 187KB Share SPL VivaGel BV regulatory approvals continue in Asia 03/09/19 PRICE SENSITIVE download Created with Sketch. 127.57KB Share SPL Positive results with Targeted DEP using antibody fragment 29/08/19 PRICE SENSITIVE download Created with Sketch. 100.01KB Share SPL Appendix 4G - Corporate Governance Statement 28/08/19 download Created with Sketch. 126.17KB Share SPL Starpharma annual report and full year financial results 28/08/19 PRICE SENSITIVE download Created with Sketch. 4.37MB Share SPL Promising efficacy signals observed in ongoing DEP trials 28/08/19 PRICE SENSITIVE download Created with Sketch. 246.47KB Share SPL First Asian Regulatory Approvals Received for VivaGel BV 15/08/19 PRICE SENSITIVE download Created with Sketch. 61.81KB Share SPL Starpharma commences phase 1/2 DEP irinotecan trial 08/08/19 PRICE SENSITIVE download Created with Sketch. 133.55KB Share SPL Appendix 3B 29/07/19 download Created with Sketch. 165.8KB Share SPL Quarterly Cashflow Report 16/07/19 PRICE SENSITIVE download Created with Sketch. 210.9KB Share SPL Shareholder Update July 2019 01/07/19 download Created with Sketch. 599.58KB Share SPL VivaGel BV launched in Europe 27/06/19 PRICE SENSITIVE download Created with Sketch. 69.36KB Share SPL Starpharma presents at Macquarie Emerging Leaders Forum 20/06/19 download Created with Sketch. 42.09KB Share SPL US patent granted for DEP Bcl2/xL inhibitor conjugates 12/06/19 download Created with Sketch. 62.07KB Share SPL Okamoto launches VivaGel condom in Japan 04/06/19 download Created with Sketch. 114.24KB Share SPL Starpharma signs second oncology agreement with AstraZeneca 03/06/19 PRICE SENSITIVE download Created with Sketch. 125.34KB Share SPL Starpharma presents at UBS Healthcare Conference 29/05/19 download Created with Sketch. 41.87KB Share SPL DEP irinotecan combination outperforms in colon cancel model 24/05/19 PRICE SENSITIVE download Created with Sketch. 213.21KB Share
